Summary
Edwards Lifesciences Corporation (EW) filed a Form 8-K on July 21, 2011, to report its financial results for the second quarter of 2011. The report itself primarily serves as a cover for a press release (Exhibit 99.1) detailing these results, rather than providing extensive operational commentary within the 8-K document. Investors should refer to the attached press release for the specifics of the quarterly performance.
Key Highlights
- 1Edwards Lifesciences filed an 8-K on July 21, 2011.
- 2The filing announces the company's financial results for the second quarter of 2011.
- 3The primary content of the filing is Exhibit 99.1, a press release dated July 21, 2011.
- 4This press release contains the detailed financial results for Q2 2011.
- 5The 8-K itself does not contain the detailed financial results but references the press release.
- 6The report confirms that the press release is furnished under Item 2.02, meaning it is not deemed 'filed' for liability purposes.
- 7The filing is signed by Thomas M. Abate, Corporate Vice President and Chief Financial Officer.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide access to Edwards Lifesciences' financial results for the second quarter of 2011, as detailed in an accompanying press release.
The detailed financial results for the second quarter of 2011 are contained within Exhibit 99.1, which is a press release attached to this 8-K filing. Investors should review this press release for specific figures and performance details.
No, according to the filing, the information furnished under Item 2.02, including the press release, is furnished and not deemed 'filed' for the purposes of the Securities Exchange Act of 1934. This distinction is important regarding legal liability.